[{"address1": "2 Bloor Street West", "address2": "Suite 903 7th Floor", "city": "Toronto", "state": "ON", "zip": "M4W 3E2", "country": "Canada", "phone": "416 648 5555", "website": "https://www.medicenna.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Fahar  Merchant Ph.D.", "age": 68, "title": "Founder, Chairman, President & CEO", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 553755, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rosemina  Merchant B.Sc., M.E.Sc", "age": 68, "title": "Founder & Chief Development Officer", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 358193, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Hyman CA, CBV", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2025, "totalPay": 87046, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel R. Denmeade M.D.", "title": "Scientific Advisor", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7, "open": 0.6899, "dayLow": 0.6751, "dayHigh": 0.6914, "regularMarketPreviousClose": 0.7, "regularMarketOpen": 0.6899, "regularMarketDayLow": 0.6751, "regularMarketDayHigh": 0.6914, "payoutRatio": 0.0, "beta": 1.87, "forwardPE": -4.047059, "volume": 6250, "regularMarketVolume": 6250, "averageVolume": 126931, "averageVolume10days": 98250, "averageDailyVolume10Day": 98250, "bid": 0.69, "ask": 0.692, "bidSize": 9000, "askSize": 5000, "marketCap": 57387068, "fiftyTwoWeekLow": 0.573, "fiftyTwoWeekHigh": 1.43, "allTimeHigh": 6.84, "allTimeLow": 0.151, "fiftyDayAverage": 0.8673, "twoHundredDayAverage": 0.767265, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 41776388, "profitMargins": 0.0, "floatShares": 60632606, "sharesOutstanding": 83411435, "sharesShort": 109389, "sharesShortPriorMonth": 278169, "sharesShortPreviousMonthDate": 1694736000, "dateShortInterest": 1697155200, "sharesPercentSharesOut": 0.0016, "heldPercentInsiders": 0.20996, "heldPercentInstitutions": 0.06317, "shortRatio": 0.77, "shortPercentOfFloat": 0.0069999998, "impliedSharesOutstanding": 83411435, "bookValue": 0.08922174, "priceToBook": 7.7111254, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -13815000, "trailingEps": -0.12, "forwardEps": -0.17, "enterpriseToEbitda": -1.917, "52WeekChange": -0.23076922, "SandP52WeekChange": 0.15024745, "quoteType": "EQUITY", "currentPrice": 0.688, "targetHighPrice": 4.0, "targetLowPrice": 2.5, "targetMeanPrice": 3.25, "targetMedianPrice": 3.25, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 15748000, "totalCashPerShare": 0.189, "ebitda": -21798000, "totalDebt": 149000, "quickRatio": 3.815, "currentRatio": 4.008, "debtToEquity": 1.455, "returnOnAssets": -0.53507, "returnOnEquity": -0.91206, "freeCashflow": -9880250, "operatingCashflow": -17034000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "MDNAF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1510583400000, "regularMarketChange": -0.011999965, "regularMarketDayRange": "0.6751 - 0.6914", "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 126931, "fiftyTwoWeekLowChange": 0.11500001, "fiftyTwoWeekLowChangePercent": 0.2006981, "fiftyTwoWeekRange": "0.573 - 1.43", "fiftyTwoWeekHighChange": -0.7419999, "fiftyTwoWeekHighChangePercent": -0.5188811, "fiftyTwoWeekChangePercent": -23.076921, "earningsTimestampStart": 1770930000, "earningsTimestampEnd": 1770930000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.12, "epsForward": -0.17, "marketState": "CLOSED", "shortName": "Medicenna Therapeutics Corp.", "regularMarketChangePercent": -1.7142807, "regularMarketPrice": 0.688, "fiftyDayAverageChange": -0.17929995, "fiftyDayAverageChangePercent": -0.2067335, "twoHundredDayAverageChange": -0.079265, "twoHundredDayAverageChangePercent": -0.1033085, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "exchange": "OQX", "messageBoardId": "finmb_245978917", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1769202000, "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]